The FDA is holding a forum this month to address MRI safety concerns and find ways to cut incidents. Industry leaders agree there should be safety standards in place, but are mixed on whether federal regulation is needed. What do you think?
The FDA is holding a forum this month to address MRI safety concerns and find ways to cut incidents. Industry leaders agree there should be safety standards in place, but are mixed on whether federal regulation is needed.
What do you think? Vote here and tell us more in the comments below.
Seven Takeaways from New CT and MRI Guidelines for Ovarian Cancer Staging
January 20th 2025In an update of previous guidelines from the European Society of Urogenital Radiology published in 2010, a 21-expert panel offered consensus recommendations on the utility of CT, MRI and PET-CT in the staging and follow-up imaging for patients with ovarian cancer.